1: Turner IB, Rawlins MD, Wood P, James OF. Flumecinol for the treatment of pruritus associated with primary biliary cirrhosis. Aliment Pharmacol Ther. 1994 Jun;8(3):337-42. PubMed PMID: 7918930.
2: Szabó I, Vas A, Renczes G. Effect of flumecinol (Zixoryn) on the cytochrome P450 and cytochrome P448 dependent hepatic microsomal monooxygenase activities in male rats. Acta Physiol Hung. 1992;79(1):23-7. PubMed PMID: 1288050.
3: Klebovich I, Vereczkey L, Kerpel-Fronius S, Ringwald G, Bodrogligeti I. Pharmacokinetic studies of flumecinol in man and dog. Eur J Drug Metab Pharmacokinet. 1982;7(2):99-104. PubMed PMID: 7117300.
4: Klebovich I, Vereczkey L, Tóth E, Tamás J, Mák M, Jalsovszky G, Holly S. Metabolism of flumecinol in humans. Xenobiotica. 1987 Oct;17(10):1247-58. PubMed PMID: 3424871.
5: Klebovich I, Csetényi J, Kerpel-Fronius S, Vereczkey L. Pharmacokinetic studies of [14C]-flumecinol in humans. Arzneimittelforschung. 1987 Mar;37(3):368-71. PubMed PMID: 3593454.
6: Klebovich I, Trafikánt G, Vereczkey L. Pharmacokinetics of flumecinol in rats. Acta Pharm Hung. 1988 Jan;58(1):1-7. PubMed PMID: 3376768.
7: Sylvia LA, Gerig JT. Fluorine NMR studies of the metabolism of flumecinol (3-trifluoromethyl-alpha-ethylbenzhydrol). Drug Metab Dispos. 1993 Jan-Feb;21(1):105-13. PubMed PMID: 8095202.
8: Görög S, Herényi B, Rényei M. Estimation of impurity profiles of drugs and related materials. Part 9: HPLC investigation of flumecinol. J Pharm Biomed Anal. 1992 Oct-Dec;10(10-12):831-5. PubMed PMID: 1298390.
9: Kulsár-Gergely J, Kulcsár A. Hormonal environment and age influencing the activity of flumecinol, a synthetic enzyme inducer. Arzneimittelforschung. 1981;31(12):2101-3. PubMed PMID: 7199306.
10: Silva M, Gil L. Flumecinol, a novel inducer of testosterone 16 alpha-hydroxylation in male rats. Xenobiotica. 1990 Jul;20(7):689-97. PubMed PMID: 2238704.
11: Tamás J, Mák M, Klebovich I, Vereczkey L, Tóth E. Mass spectrometric characterization of some human metabolites of flumecinol. Biomed Environ Mass Spectrom. 1988 Feb 15;15(4):229-32. PubMed PMID: 3370363.
12: Imre K, László V, József T, Mariann M, György J, Sándor H. Metabolism of flumecinol in rats. Acta Pharm Hung. 1988 Sep;58(5):221-31. PubMed PMID: 3239397.
13: Morvay J, Török J. Effect of 3-trifluoromethyl-alpha-ethylbenzhydrol (flumecinol) on lipid peroxidation in early human placenta. Acta Physiol Hung. 1988;71(2):207-11. PubMed PMID: 3389164.
14: Klebovich I, Kapás M, Vereczkey L. Capillary gas chromatographic method for determination of flumecinol in plasma and saliva. J Chromatogr. 1983 Mar 11;273(1):207-12. PubMed PMID: 6853652.
15: Vezekenyi Z, Ferenci J, Radnai B, Horvath T, Past T, Nagy L, Jávor T. Human tolerance of flumecinol (Zixoryn, RGH-3332), its regime and dosage in healthy volunteers. Int J Clin Pharmacol Res. 1983;3(2):77-88. PubMed PMID: 6679516.
16: Klebovich I, Vereczkey L. Gas chromatographic method for the determination of flumecinol in biological fluids. J Chromatogr. 1980 Dec 12;221(2):403-7. PubMed PMID: 7217310.
17: Siemens W, Xander C, Meerpohl JJ, Buroh S, Antes G, Schwarzer G, Becker G. Pharmacological interventions for pruritus in adult palliative care patients. Cochrane Database Syst Rev. 2016 Nov 16;11:CD008320. Review. PubMed PMID: 27849111.
18: Görög S, Rényei M, Herényi B. The changing role of ultraviolet spectroscopy in drug analysis. J Pharm Biomed Anal. 1989;7(12):1527-33. PubMed PMID: 2490539.
19: Lahtela JT, Gachalyi B, Eksymä S, Hämäläinen A, Sotaniemi EA. The effect of liver microsomal enzyme inducing and inhibiting drugs on insulin mediated glucose metabolism in man. Br J Clin Pharmacol. 1986 Jan;21(1):19-26. PubMed PMID: 3511933; PubMed Central PMCID: PMC1400813.
20: Siemens W, Xander C, Meerpohl JJ, Antes G, Becker G. Drug treatments for pruritus in adult palliative care. Dtsch Arztebl Int. 2014 Dec 12;111(50):863-70. doi: 10.3238/arztebl.2014.0863. Review. PubMed PMID: 25585583; PubMed Central PMCID: PMC4296209.